SCHEMBL2117287

SCHEMBL2117287

Cc1ccc(S(=O)(=O)Nc2cc(C)cc(-c3ccc(C#N)cn3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.51
MAOA P21397 2/20 0.51
HSD11B1 P28845 2/20 0.49
TP53 P04637 2/20 0.47
THRB P10828 1/20 0.47
PIK3CB P42338 1/20 0.46
GRM5 P41594 1/20 0.46
IDO1 P14902 1/20 0.44
PIK3C3 Q8NEB9 1/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALPL P05186 1/20 0.44
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KIT P10721 2/20 0.43
NPC1 O15118 1/20 0.43
BRD4 O60885 1/20 0.43
BRD1 O95696 1/20 0.43
BRPF1 P55201 1/20 0.43
BRD9 Q9H8M2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120549 0.90 STAT3 (0.48) KDM1AMAOAHSD11B1PIK3CBALDH1A1
SCHEMBL2118331 0.83 HSD11B1 (0.62) KDM1AHSD11B1TP53THRBIDO1
SCHEMBL2118641 0.82 PIK3CB (0.49) TP53PIK3CBALDH1A1KDM4EALPL
SCHEMBL15150073 0.82 KDM1A (0.78) KDM1AMAOAHSD11B1
SCHEMBL2118551 0.80 PIK3CB (0.50) TP53PIK3CBALDH1A1KDM4EMAPT
SCHEMBL2118647 0.78 PIK3CB (0.50) HSD11B1TP53PIK3CBALDH1A1KDM4E
SCHEMBL21275485 0.77 KDM4E (0.59) HSD11B1ALDH1A1KDM4E
SCHEMBL2119979 0.76 ALDH1A1 (0.47) HSD11B1TP53PIK3CBALDH1A1MAPT
SCHEMBL2118607 0.76 FFAR4 (0.54) PIK3CBALDH1A1KDM4EMAPTKIT
SCHEMBL6555449 0.75 KDM1A (0.68) KDM1ATP53THRBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1AN, HIF1A, EGLN2 KDM1A 103/4885MAOA 3369/4885HSD11B1 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.